Mark McClellan

Shefali Luthra, a healthcare policy reporter at The 19th, and Mark McClellan, director of the Duke-Margolis Center, delve into the judicial pushback against recent healthcare funding cuts. They discuss the impact of funding challenges on NIH grants and academic research. The conversation also highlights how federal judges are influencing health policy transparency and the implications for vulnerable populations amid potential Medicaid cuts. They emphasize the urgent need for strong leadership within health agencies to navigate these tumultuous changes.

Cheryl Pegus, Executive Chair at Flight Health, and Mark McClellan, Director of the Duke-Margolis Institute, discuss the vital link between healthcare funding and patient outcomes. They explore innovative funding strategies and the impact of private sector investments on healthcare delivery. The conversation highlights the need for transparency in healthcare financing and the role of collaboration in enhancing care quality. They also touch on the effects of budget cuts on medical research and the shift towards outcome-based financing in the evolving landscape of healthcare.

Mark McClellan, a physician-economist and former FDA commissioner, shares insights on healthcare policy and payment innovations. He reflects on the lessons learned from the U.S. COVID-19 response, emphasizing the need for a bipartisan review to enhance public health. McClellan discusses the evolution of Medicare Advantage, the impact of payment models on care delivery, and explores the challenges faced by the CMS Innovation Center in controlling costs. He advocates for better data and accountable payment designs to drive down expenses and improve outcomes.